April 10th 2025, 1:15pm
By Spencer Feldman
The 2025 Extraordinary Healer® Award was presented during the 50th Annual Oncology Nursing Society Congress, recognizing oncology nursing professionals' dedication and impact.
April 9th 2025, 9:00pm
By Alex Biese
CT-95 is being developed for cancers including pancreatic, ovarian and mesothelioma and other solid tumors.
April 9th 2025, 8:29pm
By John Thompson
Because the five-year relative survival rate for people with esophageal cancer is approximately 22%, this makes early detection of the essence.
April 9th 2025, 7:00pm
Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck cancer.
April 9th 2025, 5:00pm
By Linda Cohen
After living with lymphoma for 15 and a half years, my doctor has suggested reducing the dose of my medication and possibly taking me off of it.
April 9th 2025, 3:00pm
A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study.
April 9th 2025, 1:03pm
By Ryan Scott
Dr. Sheri Yolanda Prentiss discusses lymphedema as a result of cancer treatment and shares resources that exist for patients coping with this condition.
April 8th 2025, 9:00pm
The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.
April 8th 2025, 8:16pm
The American Heart Association has released a statement detailing cardiometabolic considerations for survivors of childhood cancer.
April 8th 2025, 8:00pm
By Dr. Reshma Jagsi
Radiation therapy plays an important role in reducing the risk of cancer recurrence for patients with breast cancer undergoing breast reconstruction.
April 8th 2025, 6:32pm
The FDA has approved Opdivo with Yervoy for patients 12 years old and older with MSI-H or dMMR colorectal cancer.
April 8th 2025, 5:00pm
By Jane Biehl Ph.D.
In an upside-down, topsy-turvy world, cancer can be a distraction for us.
April 8th 2025, 3:00pm
SLS009 is associated with an improvement in survival among patients with relapsed/refractory acute myeloid leukemia.
April 8th 2025, 1:46pm
Following a social media takeover with CURE, Sid Sadler sat down to talk about the topic of Kidney Cancer Awareness Month and patient advocacy.
April 7th 2025, 9:00pm
Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of patients’ diabetes status.
A Cancer Survivor Rethinks Cancer Ghosting
A Story of Staying Active After a Lung Cancer Diagnosis
Experts Discuss New Advances in Bladder Cancer Following ESMO 2025
What I Learned About Previvorship and Representation in Social Media